Global Glucosamine and Chondroitin Sulfate Market

Glucosamine and Chondroitin Sulfate Comprehensive Study by Application (Pharmaceutical, Dietary Supplements (Animal Feed, Nutraceuticals), Cosmetics, Others), Source (Bovine, Swine, Poultry, Shark, Synthetic) Players and Region - Global Market Outlook to 2030

Glucosamine and Chondroitin Sulfate Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 5.9%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
The Glucosamine and Chondroitin Sulfate market is expected to witness high demand in the forecasted period due to the increasing demand for nutraceutical products along with the prevalence of osteoarthritis. Chondroitin sulfate used in combination with ingredients, such as manganese ascorbate, glucosamine hydrochloride, and others treats osteoarthritis. Many of the uses of chondroitin sulfate are approved by the FDA. Chondroitin sulfate is mostly used to treat osteoarthritis, cataract, and urinary tract infections, which is anticipated to drive the overall demand for the product over the forecast period. It is also used in the form of medicines to improve digestive function, enhance liver function, lower blood sugar, and inhibit tumor metastasis.

AttributesDetails
Study Period2018-2030
Base Year2023
High Growth MarketAsia Pacific
UnitValue (USD Million)
Key Companies ProfiledShandong Runxin Biotechnology (China), TSI Group (Canada), Synutra Ingredients (United States), Yantai Ruikangda Biochemical Products (United States), S.A.U. Seikagaku Corporation (Japan), Qingdao WanTuMing Biological Products (China), Sioux Pharm (United States), Pacific Rainbow International (United States), Summit Nutritionals International (United States) and Bioiberica (Spain)


According to AMA, the market for Glucosamine and Chondroitin Sulfate is expected to register a CAGR of 5.9% during the forecast period to 2030. This growth is primarily driven by Increasing Application in Various End-User Industries and The Growing Demand for Dietary Supplements.

Globally, a noticeable market trend is evident The Rising Health-Conscious Customers and The Aging Population for Joint Health Supplements The Pharmaceuticals sector in the North America region has been increasing at a sustainable rate, and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as Shandong Runxin Biotechnology (China), TSI Group (Canada), Synutra Ingredients (United States), Yantai Ruikangda Biochemical Products (United States), S.A.U. Seikagaku Corporation (Japan), Qingdao WanTuMing Biological Products (China), Sioux Pharm (United States), Pacific Rainbow International (United States), Summit Nutritionals International (United States) and Bioiberica (Spain), etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years. Leading key players are focusing on strategic partnerships to improve their products and services. Companies are focusing on increasing their client base to strengthen market position and to enhance product & service offerings.

Key Developments in the Market:
In April 2023, Koninklijke DSM N.V. announced its intention to acquire the Nutrition & Health business of ADM for €3.4 billion. This deal would expand DSM's presence in the dietary supplement market, including glucosamine and chondroitin products.
In March 2023, Arjuna Natural Extracts Ltd. and NutraIngredients.com partnered to launch a new online platform for sourcing and selling natural ingredients, including glucosamine and chondroitin.

Influencing Trend:
The Rising Health-Conscious Customers and The Aging Population for Joint Health Supplements and The Increasing Use of Sodium Chondroitin Pharmaceutical Grade Sulfate

Market Growth Drivers:
Increasing Application in Various End-User Industries and The Growing Demand for Dietary Supplements

Challenges:
The Stringent Government Regulations Associated with Glucosamine and Chondroitin Sulfate

Restraints:
Fluctuating Raw Material Prices

Opportunities:
Increased Application of Chondroitin Sulfate as an Anti-Inflammatory and Soothing Agent in Cosmetic Products

AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts but also includes significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints in Glucosamine and Chondroitin Sulfate Market
- Analysis about New Entrants in Glucosamine and Chondroitin Sulfate Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis
- An Unbiased Perspective towards Market Performance & Indicators

Against this Challenging Backdrop, Glucosamine and Chondroitin Sulfate Study Sheds Light on
— The Glucosamine and Chondroitin Sulfate Market status quo and key characteristics. To end this, Analysts at AMA organize and took surveys of the Glucosamine and Chondroitin Sulfate industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Glucosamine and Chondroitin Sulfate industry is heading and what are the top priorities. Insights are drawn from financial analysis, surveys, and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold the value they currently claim or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Application
  • Pharmaceutical
  • Dietary Supplements [Animal Feed, Nutraceuticals]
  • Cosmetics
  • Others
By Source
  • Bovine
  • Swine
  • Poultry
  • Shark
  • Synthetic

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Application in Various End-User Industries
      • 3.2.2. The Growing Demand for Dietary Supplements
    • 3.3. Market Challenges
      • 3.3.1. The Stringent Government Regulations Associated with Glucosamine and Chondroitin Sulfate
    • 3.4. Market Trends
      • 3.4.1. The Rising Health-Conscious Customers and The Aging Population for Joint Health Supplements
      • 3.4.2. The Increasing Use of Sodium Chondroitin Pharmaceutical Grade Sulfate
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Glucosamine and Chondroitin Sulfate, by Application, Source and Region (value, volume and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Glucosamine and Chondroitin Sulfate (Value)
      • 5.2.1. Global Glucosamine and Chondroitin Sulfate by: Application (Value)
        • 5.2.1.1. Pharmaceutical
        • 5.2.1.2. Dietary Supplements [Animal Feed, Nutraceuticals]
        • 5.2.1.3. Cosmetics
        • 5.2.1.4. Others
      • 5.2.2. Global Glucosamine and Chondroitin Sulfate by: Source (Value)
        • 5.2.2.1. Bovine
        • 5.2.2.2. Swine
        • 5.2.2.3. Poultry
        • 5.2.2.4. Shark
        • 5.2.2.5. Synthetic
      • 5.2.3. Global Glucosamine and Chondroitin Sulfate Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
    • 5.3. Global Glucosamine and Chondroitin Sulfate (Volume)
      • 5.3.1. Global Glucosamine and Chondroitin Sulfate by: Application (Volume)
        • 5.3.1.1. Pharmaceutical
        • 5.3.1.2. Dietary Supplements [Animal Feed, Nutraceuticals]
        • 5.3.1.3. Cosmetics
        • 5.3.1.4. Others
      • 5.3.2. Global Glucosamine and Chondroitin Sulfate by: Source (Volume)
        • 5.3.2.1. Bovine
        • 5.3.2.2. Swine
        • 5.3.2.3. Poultry
        • 5.3.2.4. Shark
        • 5.3.2.5. Synthetic
      • 5.3.3. Global Glucosamine and Chondroitin Sulfate Region
        • 5.3.3.1. South America
          • 5.3.3.1.1. Brazil
          • 5.3.3.1.2. Argentina
          • 5.3.3.1.3. Rest of South America
        • 5.3.3.2. Asia Pacific
          • 5.3.3.2.1. China
          • 5.3.3.2.2. Japan
          • 5.3.3.2.3. India
          • 5.3.3.2.4. South Korea
          • 5.3.3.2.5. Taiwan
          • 5.3.3.2.6. Australia
          • 5.3.3.2.7. Rest of Asia-Pacific
        • 5.3.3.3. Europe
          • 5.3.3.3.1. Germany
          • 5.3.3.3.2. France
          • 5.3.3.3.3. Italy
          • 5.3.3.3.4. United Kingdom
          • 5.3.3.3.5. Netherlands
          • 5.3.3.3.6. Rest of Europe
        • 5.3.3.4. MEA
          • 5.3.3.4.1. Middle East
          • 5.3.3.4.2. Africa
        • 5.3.3.5. North America
          • 5.3.3.5.1. United States
          • 5.3.3.5.2. Canada
          • 5.3.3.5.3. Mexico
    • 5.4. Global Glucosamine and Chondroitin Sulfate (Price)
  • 6. Glucosamine and Chondroitin Sulfate: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Shandong Runxin Biotechnology (China)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. TSI Group (Canada)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Synutra Ingredients (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Yantai Ruikangda Biochemical Products (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. S.A.U. Seikagaku Corporation (Japan)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Qingdao WanTuMing Biological Products (China)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Sioux Pharm (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Pacific Rainbow International (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Summit Nutritionals International (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Bioiberica (Spain)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Glucosamine and Chondroitin Sulfate Sale, by Application, Source and Region (value, volume and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Glucosamine and Chondroitin Sulfate (Value)
      • 7.2.1. Global Glucosamine and Chondroitin Sulfate by: Application (Value)
        • 7.2.1.1. Pharmaceutical
        • 7.2.1.2. Dietary Supplements [Animal Feed, Nutraceuticals]
        • 7.2.1.3. Cosmetics
        • 7.2.1.4. Others
      • 7.2.2. Global Glucosamine and Chondroitin Sulfate by: Source (Value)
        • 7.2.2.1. Bovine
        • 7.2.2.2. Swine
        • 7.2.2.3. Poultry
        • 7.2.2.4. Shark
        • 7.2.2.5. Synthetic
      • 7.2.3. Global Glucosamine and Chondroitin Sulfate Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
    • 7.3. Global Glucosamine and Chondroitin Sulfate (Volume)
      • 7.3.1. Global Glucosamine and Chondroitin Sulfate by: Application (Volume)
        • 7.3.1.1. Pharmaceutical
        • 7.3.1.2. Dietary Supplements [Animal Feed, Nutraceuticals]
        • 7.3.1.3. Cosmetics
        • 7.3.1.4. Others
      • 7.3.2. Global Glucosamine and Chondroitin Sulfate by: Source (Volume)
        • 7.3.2.1. Bovine
        • 7.3.2.2. Swine
        • 7.3.2.3. Poultry
        • 7.3.2.4. Shark
        • 7.3.2.5. Synthetic
      • 7.3.3. Global Glucosamine and Chondroitin Sulfate Region
        • 7.3.3.1. South America
          • 7.3.3.1.1. Brazil
          • 7.3.3.1.2. Argentina
          • 7.3.3.1.3. Rest of South America
        • 7.3.3.2. Asia Pacific
          • 7.3.3.2.1. China
          • 7.3.3.2.2. Japan
          • 7.3.3.2.3. India
          • 7.3.3.2.4. South Korea
          • 7.3.3.2.5. Taiwan
          • 7.3.3.2.6. Australia
          • 7.3.3.2.7. Rest of Asia-Pacific
        • 7.3.3.3. Europe
          • 7.3.3.3.1. Germany
          • 7.3.3.3.2. France
          • 7.3.3.3.3. Italy
          • 7.3.3.3.4. United Kingdom
          • 7.3.3.3.5. Netherlands
          • 7.3.3.3.6. Rest of Europe
        • 7.3.3.4. MEA
          • 7.3.3.4.1. Middle East
          • 7.3.3.4.2. Africa
        • 7.3.3.5. North America
          • 7.3.3.5.1. United States
          • 7.3.3.5.2. Canada
          • 7.3.3.5.3. Mexico
    • 7.4. Global Glucosamine and Chondroitin Sulfate (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Glucosamine and Chondroitin Sulfate: by Application(USD Million)
  • Table 2. Glucosamine and Chondroitin Sulfate Pharmaceutical , by Region USD Million (2018-2023)
  • Table 3. Glucosamine and Chondroitin Sulfate Dietary Supplements [Animal Feed, Nutraceuticals] , by Region USD Million (2018-2023)
  • Table 4. Glucosamine and Chondroitin Sulfate Cosmetics , by Region USD Million (2018-2023)
  • Table 5. Glucosamine and Chondroitin Sulfate Others , by Region USD Million (2018-2023)
  • Table 6. Glucosamine and Chondroitin Sulfate: by Source(USD Million)
  • Table 7. Glucosamine and Chondroitin Sulfate Bovine , by Region USD Million (2018-2023)
  • Table 8. Glucosamine and Chondroitin Sulfate Swine , by Region USD Million (2018-2023)
  • Table 9. Glucosamine and Chondroitin Sulfate Poultry , by Region USD Million (2018-2023)
  • Table 10. Glucosamine and Chondroitin Sulfate Shark , by Region USD Million (2018-2023)
  • Table 11. Glucosamine and Chondroitin Sulfate Synthetic , by Region USD Million (2018-2023)
  • Table 12. South America Glucosamine and Chondroitin Sulfate, by Country USD Million (2018-2023)
  • Table 13. South America Glucosamine and Chondroitin Sulfate, by Application USD Million (2018-2023)
  • Table 14. South America Glucosamine and Chondroitin Sulfate, by Source USD Million (2018-2023)
  • Table 15. Brazil Glucosamine and Chondroitin Sulfate, by Application USD Million (2018-2023)
  • Table 16. Brazil Glucosamine and Chondroitin Sulfate, by Source USD Million (2018-2023)
  • Table 17. Argentina Glucosamine and Chondroitin Sulfate, by Application USD Million (2018-2023)
  • Table 18. Argentina Glucosamine and Chondroitin Sulfate, by Source USD Million (2018-2023)
  • Table 19. Rest of South America Glucosamine and Chondroitin Sulfate, by Application USD Million (2018-2023)
  • Table 20. Rest of South America Glucosamine and Chondroitin Sulfate, by Source USD Million (2018-2023)
  • Table 21. Asia Pacific Glucosamine and Chondroitin Sulfate, by Country USD Million (2018-2023)
  • Table 22. Asia Pacific Glucosamine and Chondroitin Sulfate, by Application USD Million (2018-2023)
  • Table 23. Asia Pacific Glucosamine and Chondroitin Sulfate, by Source USD Million (2018-2023)
  • Table 24. China Glucosamine and Chondroitin Sulfate, by Application USD Million (2018-2023)
  • Table 25. China Glucosamine and Chondroitin Sulfate, by Source USD Million (2018-2023)
  • Table 26. Japan Glucosamine and Chondroitin Sulfate, by Application USD Million (2018-2023)
  • Table 27. Japan Glucosamine and Chondroitin Sulfate, by Source USD Million (2018-2023)
  • Table 28. India Glucosamine and Chondroitin Sulfate, by Application USD Million (2018-2023)
  • Table 29. India Glucosamine and Chondroitin Sulfate, by Source USD Million (2018-2023)
  • Table 30. South Korea Glucosamine and Chondroitin Sulfate, by Application USD Million (2018-2023)
  • Table 31. South Korea Glucosamine and Chondroitin Sulfate, by Source USD Million (2018-2023)
  • Table 32. Taiwan Glucosamine and Chondroitin Sulfate, by Application USD Million (2018-2023)
  • Table 33. Taiwan Glucosamine and Chondroitin Sulfate, by Source USD Million (2018-2023)
  • Table 34. Australia Glucosamine and Chondroitin Sulfate, by Application USD Million (2018-2023)
  • Table 35. Australia Glucosamine and Chondroitin Sulfate, by Source USD Million (2018-2023)
  • Table 36. Rest of Asia-Pacific Glucosamine and Chondroitin Sulfate, by Application USD Million (2018-2023)
  • Table 37. Rest of Asia-Pacific Glucosamine and Chondroitin Sulfate, by Source USD Million (2018-2023)
  • Table 38. Europe Glucosamine and Chondroitin Sulfate, by Country USD Million (2018-2023)
  • Table 39. Europe Glucosamine and Chondroitin Sulfate, by Application USD Million (2018-2023)
  • Table 40. Europe Glucosamine and Chondroitin Sulfate, by Source USD Million (2018-2023)
  • Table 41. Germany Glucosamine and Chondroitin Sulfate, by Application USD Million (2018-2023)
  • Table 42. Germany Glucosamine and Chondroitin Sulfate, by Source USD Million (2018-2023)
  • Table 43. France Glucosamine and Chondroitin Sulfate, by Application USD Million (2018-2023)
  • Table 44. France Glucosamine and Chondroitin Sulfate, by Source USD Million (2018-2023)
  • Table 45. Italy Glucosamine and Chondroitin Sulfate, by Application USD Million (2018-2023)
  • Table 46. Italy Glucosamine and Chondroitin Sulfate, by Source USD Million (2018-2023)
  • Table 47. United Kingdom Glucosamine and Chondroitin Sulfate, by Application USD Million (2018-2023)
  • Table 48. United Kingdom Glucosamine and Chondroitin Sulfate, by Source USD Million (2018-2023)
  • Table 49. Netherlands Glucosamine and Chondroitin Sulfate, by Application USD Million (2018-2023)
  • Table 50. Netherlands Glucosamine and Chondroitin Sulfate, by Source USD Million (2018-2023)
  • Table 51. Rest of Europe Glucosamine and Chondroitin Sulfate, by Application USD Million (2018-2023)
  • Table 52. Rest of Europe Glucosamine and Chondroitin Sulfate, by Source USD Million (2018-2023)
  • Table 53. MEA Glucosamine and Chondroitin Sulfate, by Country USD Million (2018-2023)
  • Table 54. MEA Glucosamine and Chondroitin Sulfate, by Application USD Million (2018-2023)
  • Table 55. MEA Glucosamine and Chondroitin Sulfate, by Source USD Million (2018-2023)
  • Table 56. Middle East Glucosamine and Chondroitin Sulfate, by Application USD Million (2018-2023)
  • Table 57. Middle East Glucosamine and Chondroitin Sulfate, by Source USD Million (2018-2023)
  • Table 58. Africa Glucosamine and Chondroitin Sulfate, by Application USD Million (2018-2023)
  • Table 59. Africa Glucosamine and Chondroitin Sulfate, by Source USD Million (2018-2023)
  • Table 60. North America Glucosamine and Chondroitin Sulfate, by Country USD Million (2018-2023)
  • Table 61. North America Glucosamine and Chondroitin Sulfate, by Application USD Million (2018-2023)
  • Table 62. North America Glucosamine and Chondroitin Sulfate, by Source USD Million (2018-2023)
  • Table 63. United States Glucosamine and Chondroitin Sulfate, by Application USD Million (2018-2023)
  • Table 64. United States Glucosamine and Chondroitin Sulfate, by Source USD Million (2018-2023)
  • Table 65. Canada Glucosamine and Chondroitin Sulfate, by Application USD Million (2018-2023)
  • Table 66. Canada Glucosamine and Chondroitin Sulfate, by Source USD Million (2018-2023)
  • Table 67. Mexico Glucosamine and Chondroitin Sulfate, by Application USD Million (2018-2023)
  • Table 68. Mexico Glucosamine and Chondroitin Sulfate, by Source USD Million (2018-2023)
  • Table 69. Glucosamine and Chondroitin Sulfate Sales: by Application(K Units)
  • Table 70. Glucosamine and Chondroitin Sulfate Sales Pharmaceutical , by Region K Units (2018-2023)
  • Table 71. Glucosamine and Chondroitin Sulfate Sales Dietary Supplements [Animal Feed, Nutraceuticals] , by Region K Units (2018-2023)
  • Table 72. Glucosamine and Chondroitin Sulfate Sales Cosmetics , by Region K Units (2018-2023)
  • Table 73. Glucosamine and Chondroitin Sulfate Sales Others , by Region K Units (2018-2023)
  • Table 74. Glucosamine and Chondroitin Sulfate Sales: by Source(K Units)
  • Table 75. Glucosamine and Chondroitin Sulfate Sales Bovine , by Region K Units (2018-2023)
  • Table 76. Glucosamine and Chondroitin Sulfate Sales Swine , by Region K Units (2018-2023)
  • Table 77. Glucosamine and Chondroitin Sulfate Sales Poultry , by Region K Units (2018-2023)
  • Table 78. Glucosamine and Chondroitin Sulfate Sales Shark , by Region K Units (2018-2023)
  • Table 79. Glucosamine and Chondroitin Sulfate Sales Synthetic , by Region K Units (2018-2023)
  • Table 80. South America Glucosamine and Chondroitin Sulfate Sales, by Country K Units (2018-2023)
  • Table 81. South America Glucosamine and Chondroitin Sulfate Sales, by Application K Units (2018-2023)
  • Table 82. South America Glucosamine and Chondroitin Sulfate Sales, by Source K Units (2018-2023)
  • Table 83. Brazil Glucosamine and Chondroitin Sulfate Sales, by Application K Units (2018-2023)
  • Table 84. Brazil Glucosamine and Chondroitin Sulfate Sales, by Source K Units (2018-2023)
  • Table 85. Argentina Glucosamine and Chondroitin Sulfate Sales, by Application K Units (2018-2023)
  • Table 86. Argentina Glucosamine and Chondroitin Sulfate Sales, by Source K Units (2018-2023)
  • Table 87. Rest of South America Glucosamine and Chondroitin Sulfate Sales, by Application K Units (2018-2023)
  • Table 88. Rest of South America Glucosamine and Chondroitin Sulfate Sales, by Source K Units (2018-2023)
  • Table 89. Asia Pacific Glucosamine and Chondroitin Sulfate Sales, by Country K Units (2018-2023)
  • Table 90. Asia Pacific Glucosamine and Chondroitin Sulfate Sales, by Application K Units (2018-2023)
  • Table 91. Asia Pacific Glucosamine and Chondroitin Sulfate Sales, by Source K Units (2018-2023)
  • Table 92. China Glucosamine and Chondroitin Sulfate Sales, by Application K Units (2018-2023)
  • Table 93. China Glucosamine and Chondroitin Sulfate Sales, by Source K Units (2018-2023)
  • Table 94. Japan Glucosamine and Chondroitin Sulfate Sales, by Application K Units (2018-2023)
  • Table 95. Japan Glucosamine and Chondroitin Sulfate Sales, by Source K Units (2018-2023)
  • Table 96. India Glucosamine and Chondroitin Sulfate Sales, by Application K Units (2018-2023)
  • Table 97. India Glucosamine and Chondroitin Sulfate Sales, by Source K Units (2018-2023)
  • Table 98. South Korea Glucosamine and Chondroitin Sulfate Sales, by Application K Units (2018-2023)
  • Table 99. South Korea Glucosamine and Chondroitin Sulfate Sales, by Source K Units (2018-2023)
  • Table 100. Taiwan Glucosamine and Chondroitin Sulfate Sales, by Application K Units (2018-2023)
  • Table 101. Taiwan Glucosamine and Chondroitin Sulfate Sales, by Source K Units (2018-2023)
  • Table 102. Australia Glucosamine and Chondroitin Sulfate Sales, by Application K Units (2018-2023)
  • Table 103. Australia Glucosamine and Chondroitin Sulfate Sales, by Source K Units (2018-2023)
  • Table 104. Rest of Asia-Pacific Glucosamine and Chondroitin Sulfate Sales, by Application K Units (2018-2023)
  • Table 105. Rest of Asia-Pacific Glucosamine and Chondroitin Sulfate Sales, by Source K Units (2018-2023)
  • Table 106. Europe Glucosamine and Chondroitin Sulfate Sales, by Country K Units (2018-2023)
  • Table 107. Europe Glucosamine and Chondroitin Sulfate Sales, by Application K Units (2018-2023)
  • Table 108. Europe Glucosamine and Chondroitin Sulfate Sales, by Source K Units (2018-2023)
  • Table 109. Germany Glucosamine and Chondroitin Sulfate Sales, by Application K Units (2018-2023)
  • Table 110. Germany Glucosamine and Chondroitin Sulfate Sales, by Source K Units (2018-2023)
  • Table 111. France Glucosamine and Chondroitin Sulfate Sales, by Application K Units (2018-2023)
  • Table 112. France Glucosamine and Chondroitin Sulfate Sales, by Source K Units (2018-2023)
  • Table 113. Italy Glucosamine and Chondroitin Sulfate Sales, by Application K Units (2018-2023)
  • Table 114. Italy Glucosamine and Chondroitin Sulfate Sales, by Source K Units (2018-2023)
  • Table 115. United Kingdom Glucosamine and Chondroitin Sulfate Sales, by Application K Units (2018-2023)
  • Table 116. United Kingdom Glucosamine and Chondroitin Sulfate Sales, by Source K Units (2018-2023)
  • Table 117. Netherlands Glucosamine and Chondroitin Sulfate Sales, by Application K Units (2018-2023)
  • Table 118. Netherlands Glucosamine and Chondroitin Sulfate Sales, by Source K Units (2018-2023)
  • Table 119. Rest of Europe Glucosamine and Chondroitin Sulfate Sales, by Application K Units (2018-2023)
  • Table 120. Rest of Europe Glucosamine and Chondroitin Sulfate Sales, by Source K Units (2018-2023)
  • Table 121. MEA Glucosamine and Chondroitin Sulfate Sales, by Country K Units (2018-2023)
  • Table 122. MEA Glucosamine and Chondroitin Sulfate Sales, by Application K Units (2018-2023)
  • Table 123. MEA Glucosamine and Chondroitin Sulfate Sales, by Source K Units (2018-2023)
  • Table 124. Middle East Glucosamine and Chondroitin Sulfate Sales, by Application K Units (2018-2023)
  • Table 125. Middle East Glucosamine and Chondroitin Sulfate Sales, by Source K Units (2018-2023)
  • Table 126. Africa Glucosamine and Chondroitin Sulfate Sales, by Application K Units (2018-2023)
  • Table 127. Africa Glucosamine and Chondroitin Sulfate Sales, by Source K Units (2018-2023)
  • Table 128. North America Glucosamine and Chondroitin Sulfate Sales, by Country K Units (2018-2023)
  • Table 129. North America Glucosamine and Chondroitin Sulfate Sales, by Application K Units (2018-2023)
  • Table 130. North America Glucosamine and Chondroitin Sulfate Sales, by Source K Units (2018-2023)
  • Table 131. United States Glucosamine and Chondroitin Sulfate Sales, by Application K Units (2018-2023)
  • Table 132. United States Glucosamine and Chondroitin Sulfate Sales, by Source K Units (2018-2023)
  • Table 133. Canada Glucosamine and Chondroitin Sulfate Sales, by Application K Units (2018-2023)
  • Table 134. Canada Glucosamine and Chondroitin Sulfate Sales, by Source K Units (2018-2023)
  • Table 135. Mexico Glucosamine and Chondroitin Sulfate Sales, by Application K Units (2018-2023)
  • Table 136. Mexico Glucosamine and Chondroitin Sulfate Sales, by Source K Units (2018-2023)
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Company Basic Information, Sales Area and Its Competitors
  • Table 142. Company Basic Information, Sales Area and Its Competitors
  • Table 143. Company Basic Information, Sales Area and Its Competitors
  • Table 144. Company Basic Information, Sales Area and Its Competitors
  • Table 145. Company Basic Information, Sales Area and Its Competitors
  • Table 146. Company Basic Information, Sales Area and Its Competitors
  • Table 147. Glucosamine and Chondroitin Sulfate: by Application(USD Million)
  • Table 148. Glucosamine and Chondroitin Sulfate Pharmaceutical , by Region USD Million (2025-2030)
  • Table 149. Glucosamine and Chondroitin Sulfate Dietary Supplements [Animal Feed, Nutraceuticals] , by Region USD Million (2025-2030)
  • Table 150. Glucosamine and Chondroitin Sulfate Cosmetics , by Region USD Million (2025-2030)
  • Table 151. Glucosamine and Chondroitin Sulfate Others , by Region USD Million (2025-2030)
  • Table 152. Glucosamine and Chondroitin Sulfate: by Source(USD Million)
  • Table 153. Glucosamine and Chondroitin Sulfate Bovine , by Region USD Million (2025-2030)
  • Table 154. Glucosamine and Chondroitin Sulfate Swine , by Region USD Million (2025-2030)
  • Table 155. Glucosamine and Chondroitin Sulfate Poultry , by Region USD Million (2025-2030)
  • Table 156. Glucosamine and Chondroitin Sulfate Shark , by Region USD Million (2025-2030)
  • Table 157. Glucosamine and Chondroitin Sulfate Synthetic , by Region USD Million (2025-2030)
  • Table 158. South America Glucosamine and Chondroitin Sulfate, by Country USD Million (2025-2030)
  • Table 159. South America Glucosamine and Chondroitin Sulfate, by Application USD Million (2025-2030)
  • Table 160. South America Glucosamine and Chondroitin Sulfate, by Source USD Million (2025-2030)
  • Table 161. Brazil Glucosamine and Chondroitin Sulfate, by Application USD Million (2025-2030)
  • Table 162. Brazil Glucosamine and Chondroitin Sulfate, by Source USD Million (2025-2030)
  • Table 163. Argentina Glucosamine and Chondroitin Sulfate, by Application USD Million (2025-2030)
  • Table 164. Argentina Glucosamine and Chondroitin Sulfate, by Source USD Million (2025-2030)
  • Table 165. Rest of South America Glucosamine and Chondroitin Sulfate, by Application USD Million (2025-2030)
  • Table 166. Rest of South America Glucosamine and Chondroitin Sulfate, by Source USD Million (2025-2030)
  • Table 167. Asia Pacific Glucosamine and Chondroitin Sulfate, by Country USD Million (2025-2030)
  • Table 168. Asia Pacific Glucosamine and Chondroitin Sulfate, by Application USD Million (2025-2030)
  • Table 169. Asia Pacific Glucosamine and Chondroitin Sulfate, by Source USD Million (2025-2030)
  • Table 170. China Glucosamine and Chondroitin Sulfate, by Application USD Million (2025-2030)
  • Table 171. China Glucosamine and Chondroitin Sulfate, by Source USD Million (2025-2030)
  • Table 172. Japan Glucosamine and Chondroitin Sulfate, by Application USD Million (2025-2030)
  • Table 173. Japan Glucosamine and Chondroitin Sulfate, by Source USD Million (2025-2030)
  • Table 174. India Glucosamine and Chondroitin Sulfate, by Application USD Million (2025-2030)
  • Table 175. India Glucosamine and Chondroitin Sulfate, by Source USD Million (2025-2030)
  • Table 176. South Korea Glucosamine and Chondroitin Sulfate, by Application USD Million (2025-2030)
  • Table 177. South Korea Glucosamine and Chondroitin Sulfate, by Source USD Million (2025-2030)
  • Table 178. Taiwan Glucosamine and Chondroitin Sulfate, by Application USD Million (2025-2030)
  • Table 179. Taiwan Glucosamine and Chondroitin Sulfate, by Source USD Million (2025-2030)
  • Table 180. Australia Glucosamine and Chondroitin Sulfate, by Application USD Million (2025-2030)
  • Table 181. Australia Glucosamine and Chondroitin Sulfate, by Source USD Million (2025-2030)
  • Table 182. Rest of Asia-Pacific Glucosamine and Chondroitin Sulfate, by Application USD Million (2025-2030)
  • Table 183. Rest of Asia-Pacific Glucosamine and Chondroitin Sulfate, by Source USD Million (2025-2030)
  • Table 184. Europe Glucosamine and Chondroitin Sulfate, by Country USD Million (2025-2030)
  • Table 185. Europe Glucosamine and Chondroitin Sulfate, by Application USD Million (2025-2030)
  • Table 186. Europe Glucosamine and Chondroitin Sulfate, by Source USD Million (2025-2030)
  • Table 187. Germany Glucosamine and Chondroitin Sulfate, by Application USD Million (2025-2030)
  • Table 188. Germany Glucosamine and Chondroitin Sulfate, by Source USD Million (2025-2030)
  • Table 189. France Glucosamine and Chondroitin Sulfate, by Application USD Million (2025-2030)
  • Table 190. France Glucosamine and Chondroitin Sulfate, by Source USD Million (2025-2030)
  • Table 191. Italy Glucosamine and Chondroitin Sulfate, by Application USD Million (2025-2030)
  • Table 192. Italy Glucosamine and Chondroitin Sulfate, by Source USD Million (2025-2030)
  • Table 193. United Kingdom Glucosamine and Chondroitin Sulfate, by Application USD Million (2025-2030)
  • Table 194. United Kingdom Glucosamine and Chondroitin Sulfate, by Source USD Million (2025-2030)
  • Table 195. Netherlands Glucosamine and Chondroitin Sulfate, by Application USD Million (2025-2030)
  • Table 196. Netherlands Glucosamine and Chondroitin Sulfate, by Source USD Million (2025-2030)
  • Table 197. Rest of Europe Glucosamine and Chondroitin Sulfate, by Application USD Million (2025-2030)
  • Table 198. Rest of Europe Glucosamine and Chondroitin Sulfate, by Source USD Million (2025-2030)
  • Table 199. MEA Glucosamine and Chondroitin Sulfate, by Country USD Million (2025-2030)
  • Table 200. MEA Glucosamine and Chondroitin Sulfate, by Application USD Million (2025-2030)
  • Table 201. MEA Glucosamine and Chondroitin Sulfate, by Source USD Million (2025-2030)
  • Table 202. Middle East Glucosamine and Chondroitin Sulfate, by Application USD Million (2025-2030)
  • Table 203. Middle East Glucosamine and Chondroitin Sulfate, by Source USD Million (2025-2030)
  • Table 204. Africa Glucosamine and Chondroitin Sulfate, by Application USD Million (2025-2030)
  • Table 205. Africa Glucosamine and Chondroitin Sulfate, by Source USD Million (2025-2030)
  • Table 206. North America Glucosamine and Chondroitin Sulfate, by Country USD Million (2025-2030)
  • Table 207. North America Glucosamine and Chondroitin Sulfate, by Application USD Million (2025-2030)
  • Table 208. North America Glucosamine and Chondroitin Sulfate, by Source USD Million (2025-2030)
  • Table 209. United States Glucosamine and Chondroitin Sulfate, by Application USD Million (2025-2030)
  • Table 210. United States Glucosamine and Chondroitin Sulfate, by Source USD Million (2025-2030)
  • Table 211. Canada Glucosamine and Chondroitin Sulfate, by Application USD Million (2025-2030)
  • Table 212. Canada Glucosamine and Chondroitin Sulfate, by Source USD Million (2025-2030)
  • Table 213. Mexico Glucosamine and Chondroitin Sulfate, by Application USD Million (2025-2030)
  • Table 214. Mexico Glucosamine and Chondroitin Sulfate, by Source USD Million (2025-2030)
  • Table 215. Glucosamine and Chondroitin Sulfate Sales: by Application(K Units)
  • Table 216. Glucosamine and Chondroitin Sulfate Sales Pharmaceutical , by Region K Units (2025-2030)
  • Table 217. Glucosamine and Chondroitin Sulfate Sales Dietary Supplements [Animal Feed, Nutraceuticals] , by Region K Units (2025-2030)
  • Table 218. Glucosamine and Chondroitin Sulfate Sales Cosmetics , by Region K Units (2025-2030)
  • Table 219. Glucosamine and Chondroitin Sulfate Sales Others , by Region K Units (2025-2030)
  • Table 220. Glucosamine and Chondroitin Sulfate Sales: by Source(K Units)
  • Table 221. Glucosamine and Chondroitin Sulfate Sales Bovine , by Region K Units (2025-2030)
  • Table 222. Glucosamine and Chondroitin Sulfate Sales Swine , by Region K Units (2025-2030)
  • Table 223. Glucosamine and Chondroitin Sulfate Sales Poultry , by Region K Units (2025-2030)
  • Table 224. Glucosamine and Chondroitin Sulfate Sales Shark , by Region K Units (2025-2030)
  • Table 225. Glucosamine and Chondroitin Sulfate Sales Synthetic , by Region K Units (2025-2030)
  • Table 226. South America Glucosamine and Chondroitin Sulfate Sales, by Country K Units (2025-2030)
  • Table 227. South America Glucosamine and Chondroitin Sulfate Sales, by Application K Units (2025-2030)
  • Table 228. South America Glucosamine and Chondroitin Sulfate Sales, by Source K Units (2025-2030)
  • Table 229. Brazil Glucosamine and Chondroitin Sulfate Sales, by Application K Units (2025-2030)
  • Table 230. Brazil Glucosamine and Chondroitin Sulfate Sales, by Source K Units (2025-2030)
  • Table 231. Argentina Glucosamine and Chondroitin Sulfate Sales, by Application K Units (2025-2030)
  • Table 232. Argentina Glucosamine and Chondroitin Sulfate Sales, by Source K Units (2025-2030)
  • Table 233. Rest of South America Glucosamine and Chondroitin Sulfate Sales, by Application K Units (2025-2030)
  • Table 234. Rest of South America Glucosamine and Chondroitin Sulfate Sales, by Source K Units (2025-2030)
  • Table 235. Asia Pacific Glucosamine and Chondroitin Sulfate Sales, by Country K Units (2025-2030)
  • Table 236. Asia Pacific Glucosamine and Chondroitin Sulfate Sales, by Application K Units (2025-2030)
  • Table 237. Asia Pacific Glucosamine and Chondroitin Sulfate Sales, by Source K Units (2025-2030)
  • Table 238. China Glucosamine and Chondroitin Sulfate Sales, by Application K Units (2025-2030)
  • Table 239. China Glucosamine and Chondroitin Sulfate Sales, by Source K Units (2025-2030)
  • Table 240. Japan Glucosamine and Chondroitin Sulfate Sales, by Application K Units (2025-2030)
  • Table 241. Japan Glucosamine and Chondroitin Sulfate Sales, by Source K Units (2025-2030)
  • Table 242. India Glucosamine and Chondroitin Sulfate Sales, by Application K Units (2025-2030)
  • Table 243. India Glucosamine and Chondroitin Sulfate Sales, by Source K Units (2025-2030)
  • Table 244. South Korea Glucosamine and Chondroitin Sulfate Sales, by Application K Units (2025-2030)
  • Table 245. South Korea Glucosamine and Chondroitin Sulfate Sales, by Source K Units (2025-2030)
  • Table 246. Taiwan Glucosamine and Chondroitin Sulfate Sales, by Application K Units (2025-2030)
  • Table 247. Taiwan Glucosamine and Chondroitin Sulfate Sales, by Source K Units (2025-2030)
  • Table 248. Australia Glucosamine and Chondroitin Sulfate Sales, by Application K Units (2025-2030)
  • Table 249. Australia Glucosamine and Chondroitin Sulfate Sales, by Source K Units (2025-2030)
  • Table 250. Rest of Asia-Pacific Glucosamine and Chondroitin Sulfate Sales, by Application K Units (2025-2030)
  • Table 251. Rest of Asia-Pacific Glucosamine and Chondroitin Sulfate Sales, by Source K Units (2025-2030)
  • Table 252. Europe Glucosamine and Chondroitin Sulfate Sales, by Country K Units (2025-2030)
  • Table 253. Europe Glucosamine and Chondroitin Sulfate Sales, by Application K Units (2025-2030)
  • Table 254. Europe Glucosamine and Chondroitin Sulfate Sales, by Source K Units (2025-2030)
  • Table 255. Germany Glucosamine and Chondroitin Sulfate Sales, by Application K Units (2025-2030)
  • Table 256. Germany Glucosamine and Chondroitin Sulfate Sales, by Source K Units (2025-2030)
  • Table 257. France Glucosamine and Chondroitin Sulfate Sales, by Application K Units (2025-2030)
  • Table 258. France Glucosamine and Chondroitin Sulfate Sales, by Source K Units (2025-2030)
  • Table 259. Italy Glucosamine and Chondroitin Sulfate Sales, by Application K Units (2025-2030)
  • Table 260. Italy Glucosamine and Chondroitin Sulfate Sales, by Source K Units (2025-2030)
  • Table 261. United Kingdom Glucosamine and Chondroitin Sulfate Sales, by Application K Units (2025-2030)
  • Table 262. United Kingdom Glucosamine and Chondroitin Sulfate Sales, by Source K Units (2025-2030)
  • Table 263. Netherlands Glucosamine and Chondroitin Sulfate Sales, by Application K Units (2025-2030)
  • Table 264. Netherlands Glucosamine and Chondroitin Sulfate Sales, by Source K Units (2025-2030)
  • Table 265. Rest of Europe Glucosamine and Chondroitin Sulfate Sales, by Application K Units (2025-2030)
  • Table 266. Rest of Europe Glucosamine and Chondroitin Sulfate Sales, by Source K Units (2025-2030)
  • Table 267. MEA Glucosamine and Chondroitin Sulfate Sales, by Country K Units (2025-2030)
  • Table 268. MEA Glucosamine and Chondroitin Sulfate Sales, by Application K Units (2025-2030)
  • Table 269. MEA Glucosamine and Chondroitin Sulfate Sales, by Source K Units (2025-2030)
  • Table 270. Middle East Glucosamine and Chondroitin Sulfate Sales, by Application K Units (2025-2030)
  • Table 271. Middle East Glucosamine and Chondroitin Sulfate Sales, by Source K Units (2025-2030)
  • Table 272. Africa Glucosamine and Chondroitin Sulfate Sales, by Application K Units (2025-2030)
  • Table 273. Africa Glucosamine and Chondroitin Sulfate Sales, by Source K Units (2025-2030)
  • Table 274. North America Glucosamine and Chondroitin Sulfate Sales, by Country K Units (2025-2030)
  • Table 275. North America Glucosamine and Chondroitin Sulfate Sales, by Application K Units (2025-2030)
  • Table 276. North America Glucosamine and Chondroitin Sulfate Sales, by Source K Units (2025-2030)
  • Table 277. United States Glucosamine and Chondroitin Sulfate Sales, by Application K Units (2025-2030)
  • Table 278. United States Glucosamine and Chondroitin Sulfate Sales, by Source K Units (2025-2030)
  • Table 279. Canada Glucosamine and Chondroitin Sulfate Sales, by Application K Units (2025-2030)
  • Table 280. Canada Glucosamine and Chondroitin Sulfate Sales, by Source K Units (2025-2030)
  • Table 281. Mexico Glucosamine and Chondroitin Sulfate Sales, by Application K Units (2025-2030)
  • Table 282. Mexico Glucosamine and Chondroitin Sulfate Sales, by Source K Units (2025-2030)
  • Table 283. Research Programs/Design for This Report
  • Table 284. Key Data Information from Secondary Sources
  • Table 285. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Glucosamine and Chondroitin Sulfate: by Application USD Million (2018-2023)
  • Figure 5. Global Glucosamine and Chondroitin Sulfate: by Source USD Million (2018-2023)
  • Figure 6. South America Glucosamine and Chondroitin Sulfate Share (%), by Country
  • Figure 7. Asia Pacific Glucosamine and Chondroitin Sulfate Share (%), by Country
  • Figure 8. Europe Glucosamine and Chondroitin Sulfate Share (%), by Country
  • Figure 9. MEA Glucosamine and Chondroitin Sulfate Share (%), by Country
  • Figure 10. North America Glucosamine and Chondroitin Sulfate Share (%), by Country
  • Figure 11. Global Glucosamine and Chondroitin Sulfate: by Application K Units (2018-2023)
  • Figure 12. Global Glucosamine and Chondroitin Sulfate: by Source K Units (2018-2023)
  • Figure 13. South America Glucosamine and Chondroitin Sulfate Share (%), by Country
  • Figure 14. Asia Pacific Glucosamine and Chondroitin Sulfate Share (%), by Country
  • Figure 15. Europe Glucosamine and Chondroitin Sulfate Share (%), by Country
  • Figure 16. MEA Glucosamine and Chondroitin Sulfate Share (%), by Country
  • Figure 17. North America Glucosamine and Chondroitin Sulfate Share (%), by Country
  • Figure 18. Global Glucosamine and Chondroitin Sulfate share by Players 2023 (%)
  • Figure 19. Global Glucosamine and Chondroitin Sulfate share by Players (Top 3) 2023(%)
  • Figure 20. Global Glucosamine and Chondroitin Sulfate share by Players (Top 5) 2023(%)
  • Figure 21. BCG Matrix for key Companies
  • Figure 22. Shandong Runxin Biotechnology (China) Revenue, Net Income and Gross profit
  • Figure 23. Shandong Runxin Biotechnology (China) Revenue: by Geography 2023
  • Figure 24. TSI Group (Canada) Revenue, Net Income and Gross profit
  • Figure 25. TSI Group (Canada) Revenue: by Geography 2023
  • Figure 26. Synutra Ingredients (United States) Revenue, Net Income and Gross profit
  • Figure 27. Synutra Ingredients (United States) Revenue: by Geography 2023
  • Figure 28. Yantai Ruikangda Biochemical Products (United States) Revenue, Net Income and Gross profit
  • Figure 29. Yantai Ruikangda Biochemical Products (United States) Revenue: by Geography 2023
  • Figure 30. S.A.U. Seikagaku Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 31. S.A.U. Seikagaku Corporation (Japan) Revenue: by Geography 2023
  • Figure 32. Qingdao WanTuMing Biological Products (China) Revenue, Net Income and Gross profit
  • Figure 33. Qingdao WanTuMing Biological Products (China) Revenue: by Geography 2023
  • Figure 34. Sioux Pharm (United States) Revenue, Net Income and Gross profit
  • Figure 35. Sioux Pharm (United States) Revenue: by Geography 2023
  • Figure 36. Pacific Rainbow International (United States) Revenue, Net Income and Gross profit
  • Figure 37. Pacific Rainbow International (United States) Revenue: by Geography 2023
  • Figure 38. Summit Nutritionals International (United States) Revenue, Net Income and Gross profit
  • Figure 39. Summit Nutritionals International (United States) Revenue: by Geography 2023
  • Figure 40. Bioiberica (Spain) Revenue, Net Income and Gross profit
  • Figure 41. Bioiberica (Spain) Revenue: by Geography 2023
  • Figure 42. Global Glucosamine and Chondroitin Sulfate: by Application USD Million (2025-2030)
  • Figure 43. Global Glucosamine and Chondroitin Sulfate: by Source USD Million (2025-2030)
  • Figure 44. South America Glucosamine and Chondroitin Sulfate Share (%), by Country
  • Figure 45. Asia Pacific Glucosamine and Chondroitin Sulfate Share (%), by Country
  • Figure 46. Europe Glucosamine and Chondroitin Sulfate Share (%), by Country
  • Figure 47. MEA Glucosamine and Chondroitin Sulfate Share (%), by Country
  • Figure 48. North America Glucosamine and Chondroitin Sulfate Share (%), by Country
  • Figure 49. Global Glucosamine and Chondroitin Sulfate: by Application K Units (2025-2030)
  • Figure 50. Global Glucosamine and Chondroitin Sulfate: by Source K Units (2025-2030)
  • Figure 51. South America Glucosamine and Chondroitin Sulfate Share (%), by Country
  • Figure 52. Asia Pacific Glucosamine and Chondroitin Sulfate Share (%), by Country
  • Figure 53. Europe Glucosamine and Chondroitin Sulfate Share (%), by Country
  • Figure 54. MEA Glucosamine and Chondroitin Sulfate Share (%), by Country
  • Figure 55. North America Glucosamine and Chondroitin Sulfate Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Shandong Runxin Biotechnology (China)
  • TSI Group (Canada)
  • Synutra Ingredients (United States)
  • Yantai Ruikangda Biochemical Products (United States)
  • S.A.U. Seikagaku Corporation (Japan)
  • Qingdao WanTuMing Biological Products (China)
  • Sioux Pharm (United States)
  • Pacific Rainbow International (United States)
  • Summit Nutritionals International (United States)
  • Bioiberica (Spain)
Select User Access Type

Key Highlights of Report


Feb 2024 247 Pages 75 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Glucosamine and Chondroitin Sulfate Market Quantitative research analysis
Global Glucosamine and Chondroitin Sulfate Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Top performing companies in the Global Glucosamine and Chondroitin Sulfate market are Shandong Runxin Biotechnology (China), TSI Group (Canada), Synutra Ingredients (United States), Yantai Ruikangda Biochemical Products (United States), S.A.U. Seikagaku Corporation (Japan), Qingdao WanTuMing Biological Products (China), Sioux Pharm (United States), Pacific Rainbow International (United States), Summit Nutritionals International (United States) and Bioiberica (Spain), to name a few.
North America is dominating the Glucosamine and Chondroitin Sulfate Market.
"The Stringent Government Regulations Associated with Glucosamine and Chondroitin Sulfate" is seen as one of the major challenges by many Industry Players of Glucosamine and Chondroitin Sulfate Market
The Glucosamine and Chondroitin Sulfate market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get complete companies available in our research coverage.
The Glucosamine and Chondroitin Sulfate market is expected to see a steady growth rate during projected year 2023 to 2030.

Know More About Global Glucosamine and Chondroitin Sulfate Market Report?

Have a Query? Click Here

Other Related Reports

Rasagiline Tablet Comprehensive Study by Type (0.5 mg Tablet, 1 mg Tablet, Others), Application (Clinics and Hospital, Households, Caring Center, Others), Distribution Channel (Online Channels, Offli...
$ 3500
Nasal Polyposis Drug Comprehensive Study by Route of Administration (Oral, Nasal, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), Drug Class (Cortic...
$ 3650
Lymphoma Drugs Comprehensive Study by Type (Hodgkin Lymphoma (HL) Drugs, Non-Hodgkin Lymphoma (NHL) Drugs), Lymphoma Treatment Drug (Adcetris, Opdivo, Rituxan/MabThera, Imbruvica, Keytruda, Revlimid,...
$ 3450
Primary Antibodies Comprehensive Study by Type (Monoclonal Antibodies, Polyclonal Antibodies), Application (Proteomics, Drug Development, Genomics), End-users (Pharmaceutical and Biotechnological Com...
$ 3750
Anticoccidial Drugs Comprehensive Study by Type (Antibiotic Anticoccidials, Ionophore Anticoccidials, Chemical Derivative Anticoccidials), Application (Poultry, Swine, Fish, Cattle, Companion Animals...
$ 3450
Erectile Dysfunction Drugs Comprehensive Study by Type (Existing Drugs, Pipeline Drugs), Distribution Channel (Hospital Pharmacies, Private Clinics, Drug Stores, Retail Pharmacies, E-Commerce), Pipel...
$ 3750